BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2014 5:28:00 PM | Browse: 1063 | Download: 935
Publication Name World Journal of Clinical Oncology
Manuscript ID 8896
Country United Kingdom
Received
2014-01-11 13:46
Peer-Review Started
2014-01-11 15:42
To Make the First Decision
2014-01-23 17:18
Return for Revision
2014-02-09 21:20
Revised
2014-02-28 18:01
Second Decision
2014-06-11 12:27
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-06-11 12:35
Articles in Press
2014-06-11 13:12
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-07-24 14:15
Publish the Manuscript Online
2014-08-01 16:16
ISSN 2218-4333 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Topic Highlights
Article Title Apoptosis block as a barrier to effective therapy in non small cell lung cancer
Manuscript Source Invited Manuscript
All Author List Ian Paul and J Mark Jones
Funding Agency and Grant Number
Corresponding Author J Mark Jones, MD, FRCSEd(CTh), Department of Cardiothoracic Surgery, Royal Victoria Hospital, Grosvenor Road, Belfast BT12 6BA, Northern Ireland, United Kingdom. mark.jones@belfasttrust.hscni.net
Key Words Apoptosis; Lung cancer; Adjuvant therapy; Mitochondria; BAX; BAK; BCL2
Core Tip A therapeutic plateau has been reached with the treatment of non-small cell lung cancers with platinum-based combination chemotherapy. New biomarkers of prognosis as well as new therapies focusing on molecular targets are emerging helping to identify patients who are likely to benefit from therapy. These are as yet only available to the minority of patients. Drug resistance remains the major cause for treatment failure. Apoptosis block as a mechanism for drug resistance and potential routes to overcome this will be reviewed.
Publish Date 2014-08-01 16:16
Citation Paul I, Jones JM. Apoptosis block as a barrier to effective therapy in non small cell lung cancer. World J Clin Oncol 2014; 5(4): 588-594
URL http://www.wjgnet.com/2218-4333/full/v5/i4/588.htm
DOI http://dx.doi.org/10.5306/wjco.v5.i4.588
Full Article (PDF) WJCO-5-588.pdf
Full Article (Word) WJCO-5-588.doc
Manuscript File 8896-Review.docx
Answering Reviewers 8896-Answering reviewers.pdf
Copyright License Agreement 8896-Copyright assignment.pdf
Peer-review Report 8896-Peer review(s).pdf
Scientific Misconduct Check 8896-CrossCheck.jpg
Scientific Editor Work List 8896-Scientific editor work list.pdf